Performance | China Resources Pharmaceuticals' Profit Surges Over 20% Last Year

SighingCashier · 2026-03-25T00:15:52+00:00

China Pharma Holdings (03320) announced that for the full year ended December 2025, profit attributable to shareholders was 4.045 billion yuan (RMB, the same hereinafter), representing a year-on-year increase of 20.73%; earnings per share were 0.64 yuan, with a final dividend per share of 0.122 yuan.During the period, revenue was 269.574 billion yuan, up 4.62% year-on-year. The three main business segments—pharmaceuticals, pharmaceutical distribution, and drug retail, along with others—contributed revenue proportions of 16.8%, 78.7%, and 4.5% respectively.

SighingCashier

2026-03-25 00:15:52

China Resources Pharmaceutical (03320) announced that for the year ending December 2025, the attributable profit to shareholders was 4.045 billion yuan (RMB), an increase of 20.73% year-on-year; earnings per share were 0.64 yuan, with a final dividend of 0.122 yuan per share.

During the period, revenue was 269.574 billion yuan, up 4.62% year-on-year. The main business segments—pharmaceutical manufacturing, medical distribution, drug retail, and others—accounted for 16.8%, 78.7%, and 4.5% of revenue, respectively.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.